// App-Quantinova.ai

PO‐052 : Advanced Hodgkin lymphoma in the East of England Cancer Network: a 10‐year comparative analysis of outcomes for ABVD and escalated BEACOPP treated patients aged 16–59

Researchers

Presenter

  • A Collins

Principal Investigators

  • J Russell

  • A Fowler

  • M Karanth

  • C Saha

  • V Shyamsundar

  • S Docherty

  • K Maw

  • J Padayatty

  • A Hodson

  • J Wimperis

  • S Sadullah

  • N Grigoropoulos

  • B Uttenthal

  • G Follows

Medical Centers

  • Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich, UK

  • Department of Radiology, Addenbrooke's Hospital, Cambridge, United Kingdom

  • Immunology, Peterborough City Hospital, Peterborough, UK

  • Haematology, West Suffolk Hospital, Bury Saint Edmunds

  • Department of Haematology, James Paget Hospital, Great Yarmouth

  • Department of Haematology, Queen Elizabeth Hospital, King's Lynn

  • Rheumatology, Ipswich Hospitals NHS Trust, Ipswich, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved